Open Access
Antimicrobial and Amyloidogenic Activity of Peptides. Can Antimicrobial Peptides Be Used against SARS-CoV-2?
Тип публикации: Journal Article
Дата публикации: 2020-12-15
scimago Q1
wos Q1
БС1
SJR: 1.273
CiteScore: 9.0
Impact factor: 4.9
ISSN: 16616596, 14220067
PubMed ID:
33333996
Catalysis
Organic Chemistry
Inorganic Chemistry
Physical and Theoretical Chemistry
Computer Science Applications
Spectroscopy
Molecular Biology
General Medicine
Краткое описание
At present, much attention is paid to the use of antimicrobial peptides (AMPs) of natural and artificial origin to combat pathogens. AMPs have several points that determine their biological activity. We analyzed the structural properties of AMPs, as well as described their mechanism of action and impact on pathogenic bacteria and viruses. Recently published data on the development of new AMP drugs based on a combination of molecular design and genetic engineering approaches are presented. In this article, we have focused on information on the amyloidogenic properties of AMP. This review examines AMP development strategies from the perspective of the current high prevalence of antibiotic-resistant bacteria, and the potential prospects and challenges of using AMPs against infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Топ-30
Журналы
|
2
4
6
8
10
|
|
|
International Journal of Molecular Sciences
10 публикаций, 17.86%
|
|
|
Current Protein and Peptide Science
2 публикации, 3.57%
|
|
|
International Journal of Peptide Research and Therapeutics
2 публикации, 3.57%
|
|
|
Antibiotics
2 публикации, 3.57%
|
|
|
Advances in Protein Chemistry and Structural Biology
2 публикации, 3.57%
|
|
|
Biomeditsinskaya Khimiya
1 публикация, 1.79%
|
|
|
Food and Bioprocess Technology
1 публикация, 1.79%
|
|
|
Journal of Fungi
1 публикация, 1.79%
|
|
|
Molecules
1 публикация, 1.79%
|
|
|
Frontiers in Cellular and Infection Microbiology
1 публикация, 1.79%
|
|
|
Frontiers in Molecular Biosciences
1 публикация, 1.79%
|
|
|
Frontiers in Public Health
1 публикация, 1.79%
|
|
|
BMC Bioinformatics
1 публикация, 1.79%
|
|
|
Military Medical Research
1 публикация, 1.79%
|
|
|
Applied Microbiology and Biotechnology
1 публикация, 1.79%
|
|
|
Biosafety and Health
1 публикация, 1.79%
|
|
|
Biotechnology and Genetic Engineering Reviews
1 публикация, 1.79%
|
|
|
Microbiological Research
1 публикация, 1.79%
|
|
|
Biochimica et Biophysica Acta - Proteins and Proteomics
1 публикация, 1.79%
|
|
|
Science of the Total Environment
1 публикация, 1.79%
|
|
|
In Silico Pharmacology
1 публикация, 1.79%
|
|
|
Membranes
1 публикация, 1.79%
|
|
|
Medicinal Research Reviews
1 публикация, 1.79%
|
|
|
ChemistrySelect
1 публикация, 1.79%
|
|
|
Animal Gene
1 публикация, 1.79%
|
|
|
Biomaterials Science
1 публикация, 1.79%
|
|
|
Journal of Functional Biomaterials
1 публикация, 1.79%
|
|
|
Bioengineered
1 публикация, 1.79%
|
|
|
Current Pharmaceutical Design
1 публикация, 1.79%
|
|
|
2
4
6
8
10
|
Издатели
|
2
4
6
8
10
12
14
16
18
|
|
|
MDPI
18 публикаций, 32.14%
|
|
|
Springer Nature
10 публикаций, 17.86%
|
|
|
Elsevier
10 публикаций, 17.86%
|
|
|
Bentham Science Publishers Ltd.
3 публикации, 5.36%
|
|
|
Frontiers Media S.A.
3 публикации, 5.36%
|
|
|
Taylor & Francis
2 публикации, 3.57%
|
|
|
Wiley
2 публикации, 3.57%
|
|
|
Cold Spring Harbor Laboratory
2 публикации, 3.57%
|
|
|
Institute of Biochemistry
1 публикация, 1.79%
|
|
|
Royal Society of Chemistry (RSC)
1 публикация, 1.79%
|
|
|
American Physiological Society
1 публикация, 1.79%
|
|
|
American Chemical Society (ACS)
1 публикация, 1.79%
|
|
|
2
4
6
8
10
12
14
16
18
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.
Вы ученый?
Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Метрики
56
Всего цитирований:
56
Цитирований c 2024:
15
(26%)
Цитировать
ГОСТ |
RIS |
BibTex |
MLA
Цитировать
ГОСТ
Скопировать
Kurpe S. R. et al. Antimicrobial and Amyloidogenic Activity of Peptides. Can Antimicrobial Peptides Be Used against SARS-CoV-2? // International Journal of Molecular Sciences. 2020. Vol. 21. No. 24. p. 9552.
ГОСТ со всеми авторами (до 50)
Скопировать
Kurpe S. R., Grishin S. Y., Surin A. K., PANFILOV A. V., Slizen M. V., Chowdhury D. D., Галзитская О. В. Antimicrobial and Amyloidogenic Activity of Peptides. Can Antimicrobial Peptides Be Used against SARS-CoV-2? // International Journal of Molecular Sciences. 2020. Vol. 21. No. 24. p. 9552.
Цитировать
RIS
Скопировать
TY - JOUR
DO - 10.3390/ijms21249552
UR - https://doi.org/10.3390/ijms21249552
TI - Antimicrobial and Amyloidogenic Activity of Peptides. Can Antimicrobial Peptides Be Used against SARS-CoV-2?
T2 - International Journal of Molecular Sciences
AU - Kurpe, Stanislav R
AU - Grishin, Sergei Y.
AU - Surin, Alexey K.
AU - PANFILOV, ALEXANDER V.
AU - Slizen, Mikhail V
AU - Chowdhury, Dipanwita Dutta
AU - Галзитская, О. В.
PY - 2020
DA - 2020/12/15
PB - MDPI
SP - 9552
IS - 24
VL - 21
PMID - 33333996
SN - 1661-6596
SN - 1422-0067
ER -
Цитировать
BibTex (до 50 авторов)
Скопировать
@article{2020_Kurpe,
author = {Stanislav R Kurpe and Sergei Y. Grishin and Alexey K. Surin and ALEXANDER V. PANFILOV and Mikhail V Slizen and Dipanwita Dutta Chowdhury and О. В. Галзитская},
title = {Antimicrobial and Amyloidogenic Activity of Peptides. Can Antimicrobial Peptides Be Used against SARS-CoV-2?},
journal = {International Journal of Molecular Sciences},
year = {2020},
volume = {21},
publisher = {MDPI},
month = {dec},
url = {https://doi.org/10.3390/ijms21249552},
number = {24},
pages = {9552},
doi = {10.3390/ijms21249552}
}
Цитировать
MLA
Скопировать
Kurpe, Stanislav R., et al. “Antimicrobial and Amyloidogenic Activity of Peptides. Can Antimicrobial Peptides Be Used against SARS-CoV-2?.” International Journal of Molecular Sciences, vol. 21, no. 24, Dec. 2020, p. 9552. https://doi.org/10.3390/ijms21249552.